Your browser doesn't support javascript.
loading
Metabolic adaptation to tyrosine kinase inhibition in leukemia stem cells.
Qiu, Shaowei; Sheth, Vipul; Yan, Chengcheng; Liu, Juan; Chacko, Balu K; Li, Hui; Crossman, David K; Fortmann, Seth D; Aryal, Sajesan; Rennhack, Ashley; Grant, Maria B; Welner, Robert S; Paterson, Andrew J; Wende, Adam R; Darley-Usmar, Victor M; Lu, Rui; Locasale, Jason W; Bhatia, Ravi.
Affiliation
  • Qiu S; Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL.
  • Sheth V; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin, China.
  • Yan C; Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL.
  • Liu J; Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL.
  • Chacko BK; Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC.
  • Li H; Department of Pathology, Mitochondrial Medicine Laboratory, University of Alabama at Birmingham, Birmingham, AL.
  • Crossman DK; Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL.
  • Fortmann SD; Genomics Core Facility, University of Alabama at Birmingham, Birmingham, AL.
  • Aryal S; Department of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, AL.
  • Rennhack A; Medical Scientist Training Program, School of Medicine, University of Alabama at Birmingham, Birmingham, AL.
  • Grant MB; Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL.
  • Welner RS; Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL.
  • Paterson AJ; Department of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, AL.
  • Wende AR; Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL.
  • Darley-Usmar VM; Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL.
  • Lu R; Department of Pathology, Mitochondrial Medicine Laboratory, University of Alabama at Birmingham, Birmingham, AL.
  • Locasale JW; Department of Pathology, Mitochondrial Medicine Laboratory, University of Alabama at Birmingham, Birmingham, AL.
  • Bhatia R; Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL.
Blood ; 142(6): 574-588, 2023 08 10.
Article in En | MEDLINE | ID: mdl-37192295
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein-Tyrosine Kinases / Leukemia, Myelogenous, Chronic, BCR-ABL Positive Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Blood Year: 2023 Type: Article Affiliation country: Albania
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein-Tyrosine Kinases / Leukemia, Myelogenous, Chronic, BCR-ABL Positive Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Blood Year: 2023 Type: Article Affiliation country: Albania